mental depression or other mood or mental changes
Ce médicament peut aider à traiter une
Naltrexone
Maintien de l’intérêt clinique important dans la prise en charge du patient alcoolodépendant
This medicine will not cause
23%), number of drinking days
These findings support oral naltrexone at 50 mg/d and acamprosate as first-line therapies for alcohol use disorder
The placebo-controlled studies that demonstrated the efficacy of REVIA as an adjunctive treatment of alcoholism